|
|
World Psychiatry. 2003 June; 2(2): 104–113. | PMCID: PMC1525089 |
The worldwide prevalence of ADHD: is it an American condition? STEPHEN V FARAONE,1,2,3 JOSEPH SERGEANT,4 CHRISTOPHER GILLBERG,5,6 and JOSEPH BIEDERMAN1,2,3 1Department of Community Health and Epidemiology, Abramsky Hall, Queen’s University, Kingston, Ontario, K7L 3N6, Canada 2Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, MA, USA; 3Johnson and Johnson Center for Pediatric Psychopathology at the Massachusetts General Hospital, Boston, MA, USA; 4Vrije Universiteit, Amsterdam, The Netherlands; 5Göteborg University, Göteborg, Sweden; 6University of London, London, UK Attention-deficit/hyperactivity disorder (ADHD) is a behavioral disorder
that affects up to 1 in 20 children in the USA. The predominance of American
research into this disorder over the past 40 years has led to the impression
that ADHD is largely an American disorder and is much less prevalent elsewhere.
This impression was reinforced by the perception that ADHD may stem from social
and cultural factors that are most common in American society. However, another
school of thought suggested that ADHD is a behavioral disorder common to children
of many different races and societies worldwide, but that is not recognized
by the medical community, perhaps due to confusion regarding its diagnosis
and/or misconceptions regarding its adverse impact on children, their families,
and society as a whole. In this article we present the available data, with
a view to determining the worldwide prevalence of ADHD. A total of 50 studies
were identified from a MEDLINE search for the terms ADHD, ADD, HKD, or attention-deficit/hyperactivity
disorder and prevalence combined, for the years 1982 to 2001. 20 were studies
in US populations and 30 were in non-US populations. Analysis of these studies
suggests that the prevalence of ADHD is at least as high in many non-US children
as in US children, with the highest prevalence rates being seen when using
DSM-IV diagnoses. Recognition that ADHD is not purely an American disorder
and that the prevalence of this behavioral disorder in many countries is in
the same range as that in the USA will have important implications for the
psychiatric care of children. Keywords: Attention deficit disorder (ADD), attention-deficit/hyperactivity disorder (ADHD), hyperkinetic disorder (HKD), prevalence Attention-deficit/hyperactivity disorder (ADHD) is a behavioral disorder
believed to affect up to 1 in 20 children in the USA ( 1). It is characterized by symptoms of inattention and/or
impulsivity and hyperactivity which can significantly impact on many aspects
of behavior and performance, both at school and at home. In approximately
80% of children with ADHD, symptoms persist into adolescence and may even
continue into adulthood. The effects of ADHD significantly impact on the individual
throughout childhood and well into adult life, especially if not managed optimally;
people with ADHD tend to have a lower occupational status, poor social relationships,
and are more likely to commit motoring offences and develop substance abuse
( 2). Parents and siblings also suffer
as a result of the behavioral problems associated with ADHD; increased levels
of stress are common as are depression and marital discord ( 3, 4). ADHD has been extensively studied in the USA over the past 40 years and
this has led to our detailed understanding of the behavioral characteristics
of the condition as it is now defined by the American Psychiatric Association
(APA)'s DSM. However, this predominance of American research in this field
and apparent differences in the prevalence of ADHD, or hyperkinesis, as defined
by the World Health Organization (WHO) ICD, has also led to the impression
that this is largely an American disorder and is much less prevalent elsewhere.
For example, as pointed out by Taylor and Sandberg ( 5), data from studies in the late 1970s give a 20-fold greater
prevalence of childhood hyperactivity in North America compared with England. Taylor ( 5, 6)
addressed this issue in a comparison of factor analyses for seven different
studies of children from the USA ( 3),
UK, Australia, New Zealand, and Canada. He found that in all studies, descriptions
of being restless and distractable formed a coherent factor corresponding
to hyperactivity, which was distinct from antisocial behaviors such as defiance
and aggressiveness. When the scores on this hyperactivity factor were compared
from the different studies, they were found to be similar across the seven
studies. Taylor thus suggested that the prevalence of such hyperactive behavior
is probably similar across these different countries and that the apparent
20-fold difference in the prevalence of hyperactivity reflects differences
in the definition of the condition rather than real differences in behavior
between British and American children. For example, children with hyperactive
behavior may be more likely to be diagnosed as having conduct disorder in
the UK and ADHD in the USA. This lack of a true difference in behavior between American and British
children was further confirmed in a Scottish study of children referred to
a Scottish Child Guidance Service and a group of control children (matched
for age, sex, socio-economic status, and ability) ( 7).
All children were scored for hyperactivity using the Conners' 1969 Teacher
Rating Scale, as used in the USA. 4.5% of the controls were scored as hyperactive.
This figure is similar to the prevalence of hyperactivity in the USA of 3-5%
from studies using a similar definition (e.g. 8, 9). Of the referred children, 42.7% were scored
as hyperactive; this is comparable to the percentage (30-40%) of chil- dren
referred to child guidance clinics in the USA who are diagnosed as hyperactive
( 10). These data thus also suggest
that apparent differences in the prevalence of ADHD reflect differences in
diagnostic practice rather than true differences in behavior. However, the question still remains, whether ADHD is largely an American
disorder, perhaps stemming from social and cultural factors which are more
common in American society. Alternatively, is this behavioral disorder common
to children worldwide, or to a large number of races and societies, but not
recognized by the medical community, perhaps due to confusion regarding its
diagnosis and/or misconceptions regarding its adverse impact on children and
their families and society as a whole, or persistent concerns regarding its
treatment with stimulant drugs? This article reviews the available data regarding
the prevalence of ADHD in different countries and cultures with a view to
answering this question. Before presenting these data, it is necessary to consider the factors which
affect the prevalence figures arrived at in such epidemiological studies.
The most obvious of these are probably the diagnostic criteria for ADHD, which
have been evolving over the last 20-30 years since the terms 'attention deficit'
and 'hyperactivity' were introduced. Terms such as 'minimal brain dysfunction'
and 'organic brain dysfunction' have also been used to describe this behavioral
disorder but have now largely been superseded. The terms 'hyperkinetic disorder'
(HKD) and 'deficits in attention, motor control and perception' (DAMP) are
still in use in the UK and a few other European countries (HKD) and Scandinavia
(DAMP). (HKD defines a subset of patients with a particularly severe form
of ADHD.) Other factors which affect prevalence rates include characteristics
of the sample population, methods of diagnosis, and how rigorously diagnostic
criteria are applied. Each of these factors will now be considered in detail. Over the years, the diagnostic criteria for the condition now known as
ADHD have evolved as research has furthered our understanding of the distinctive
characteristics of the disorder. These developments can be mapped in the series
of definitions published by the APA in the updates to their DSM and by the
WHO revisions of the ICD. 'Attention deficit disorder with hyperactivity'
(ADD-H) was introduced as a defined disorder in the DSM-III in 1980 ( 11) and this was updated in 1987 with the
revised edition (DSM-III-R) ( 12), in
which the disorder was redefined as 'attention deficit hyperactivity disorder'
(ADHD). The disorder was redefined again in 1994 in the fourth edition of
the DSM (DSM-IV) ( 1) and named 'attentiondeficit/
hyperactivity disorder'. The WHO definitions of hyperkinesis have also been
revised from the ICD-9 definition published in 1978 to their more recent definition
in ICD-10 published in 1992. While the WHO ICD-10 definition is still used
in some countries, mainly in Europe, there is now a general move to using
the DSM-IV definition of ADHD, which should make comparison of data between
studies much easier. This move towards a consensus for the definition of ADHD should facilitate
the development of a clear picture of the worldwide epidemiology of the condition.
However, it is still complicated by differences in how rigorously all the
elements of the DSM-IV definition are applied. For example, some researchers
omit the requirement for symptoms to be present in at least two settings (e.g. 13), while others omit the requirement for
functional impairment resulting from the symptoms (e.g. 14, 15). Other factors
which affect the diagnosis of ADHD in different studies are: the informants
used to assess symptoms, e.g. whether parents and/or teachers and/or subjects;
and whether the diagnosis is based on scores on behavior checklists (e.g. 16- 18),
or from direct interviews (e.g. 15)
or both (e.g. 19, 20). Further variations in the apparent prevalence rate arise from differences
in the population surveyed. Epidemiological studies of ADHD generally either
use representative community samples or school samples. An analysis of epidemiological
studies in the USA found that community samples gave higher prevalence rates
than school samples (mean prevalence: 10.3% for community samples vs. 6.9%
for school samples) ( 21). It is generally
agreed that the prevalence of ADHD is significantly greater in boys than girls,
especially in children. Thus the ratio of males:females in the sample population
can affect the apparent prevalence and may need to be taken into account.
Similarly, the prevalence of ADHD is known to vary with age. For example,
three studies have shown decreases in prevalence with increasing age over
the age range 10-20 years ( 22), 8-15
years ( 23), and 6-14 years ( 24). Thus, even within studies of children, the age range
of the sample is likely to affect the apparent prevalence. These confounding factors make it difficult to compare the prevalence data
for ADHD from one study and from one country to another. It is necessary to
take these factors into account when comparing data from different studies. A MEDLINE search for the terms ADHD, ADD, HKD or attention-deficit/hyperactivity
disorder and prevalence, combined with screening the reference lists of the
obtained studies, identified papers reporting on the prevalence of ADHD. Papers
were then checked to ascertain the population studied and the diagnostic criteria
used. Only studies sampling from the general population or a well specified
non-referred population (e.g., schools) were included in the next stage. This
eliminated three studies that reported the prevalence of ADHD in clinic samples.
The remaining papers were analyzed according to the diagnostic criteria employed. In 50 papers, diagnoses of ADHD or ADD-H were based on DSM-III, DSM-III-R
or DSM-IV criteria and these were included in the further analysis. (Two papers
employed DSM-III criteria but only presented data for ADD without hyperactivity
and were thus excluded.) Of these 50 papers, 20 were studies of US populations
and 30 were of non-US populations. A further four papers used ICD-9 or ICD-10
diagnostic criteria (one study each from the following countries: Hong Kong,
Germany, France, and India), and another five used other definitions of hyperactivity
(one study from each of the following countries: USA, UK, Sweden, Canada,
and China). These nine papers were not included in the more detailed analysis.
However, the populations studied in these papers were all represented in the
50 papers which were included in the further analysis, with the exception
of France. Of note, no studies of ADHD in African populations were identified
(except one unpublished study of children in Johannesburg described in Yao
et al [ 25]), nor were there any studies
in Eastern Europe. The selected studies cover a period from 1982 to 2001. DSM-III studies Thirteen studies were identified which included an assessment of the prevalence
of DSM-III ADD-H in children and adolescents. These studies spanned the period
from 1982 to 1998 and included four studies of US populations and nine studies
of non-US children. Two of the more recent studies (16,26) also included assessments
employing the more recent DSM-III-R and DSM-IV diagnostic criteria and are
thus valuable for determining the effect of the diagnostic criteria on apparent
prevalence, as will be discussed later. All four studies of US populations (Table )
involved children with a mean age of 9-11 years and investigated children
within a similar age range. The prevalence rates for three of the studies
lie within the range 9.1-12%. The one study involving less than 100 children
reported a higher prevalence (18%) when teacher reports were used to determine
the diagnosis, but gave a lower value (8%) when parent ratings were used ( 26). Of note, the study of King and Young
( 27) only involved boys; the prevalence
rate of 12% at the upper end of the range for these studies is consistent
with the accepted observation that ADDH/ ADHD is more prevalent in males than
females. Shekim et al ( 28) reported
the prevalence of ADD-H, as determined from interviews with subjects, interviews
with parents, and the rate of agreement between the two methods. When the
assessment was based on the subject's reports of symptoms, a prevalence rate
of 4% was reported, and when the diagnosis was dependent on both parent and
subject reporting, this yielded a prevalence of only 2%. This suggests that
children of this age are poor informants of ADD-H/ADHD symptoms and agreement
between parents and subjects is poor, as is well recognized ( 20, 29, 30). | Table 1Studies assessing prevalence of ADHD symptoms as defined by DSM-III in
US children and adolescents |
Of the nine studies in non-US populations, two were in adolescents (aged
15 years) ( 31, 32) and reported prevalence rates of less than 1%. The remaining
seven studies (Table ) involved children
aged 4-16 years and with mean ages of 7-11 years, and thus constitute a homogeneous
age range comparable to that of the US studies. These studies reported prevalence
rates in the range of 5.8-11.2%, except for the study of Taylor et al ( 33), which involved only boys and reported
a higher prevalence of 16.6%, as might be expected for a totally male sample.
The study of Leung et al ( 34) also
involved a totally male population; thus the 6.1% prevalence of hyperactivity
in this study may indicate a lower overall prevalence in Hong Kong compared
to other countries. The authors suggested that both biological and cultural
differences may account for the prevalence rates of hyperactivity in Chinese
children. Interestingly, Taylor and Sandberg's study ( 5) also reported on the prevalence of hyperkinesis for their
population of school boys aged 6-8 years. This value, 1.7%, is approximately
one-tenth that of the reported prevalence of ADDH in the same study. This
difference in prevalence between hyperkinesis and ADD-H further supports Taylor's
suggestion than the apparent difference in prevalence of ADHD/hyperactivity
between US and British children stems from the difference in definition of
the disorder rather than true behavioral differences between the two countries. | Table 2Studies assessing prevalence of ADHD symptoms as defined by DSM-III in
non-US children and adolescents |
DSM-III-R studies A total of 22 studies were identified which had assessed the prevalence
of ADHD using DSM-III-R criteria. These included 10 studies of US populations
and 12 studies of non-US populations and were performed over a 12-year period
from 1989 to 2001. As with the DSM-III studies, several have also included
diagnosis using DSMIII or DSM-IV criteria and hence allow an estimation of
the impact of diagnostic criteria on the apparent prevalence of ADHD/ADD-H. The details of the 10 US studies are given in Table , with the exception of one study, which assessed prevalence
in late adolescence and in young adults (age 16-22 years) ( 35). Five of the remaining studies involved children aged
5-14 years and with a mean age between 8 and 10 years ( 17, 26, 36- 38). A sixth study
( 22) presented prevalence data for
subjects aged 10-20 years, but reported prevalence figures for three age ranges
within the population; the lowest age range (10-13 years) fell within that
of the other five studies and thus was included in the analysis. Data from
these six studies gave prevalence rates in the range 7.1-12.8%, with the outlier
values of 26% based on teacher assessments in the Newcorn et al study ( 26), and 2.8% in the study of August et al
( 37). The Newcorn et al study involved
less than 100 subjects from an inner city school and thus may not be representative
of the general population. Also, the prevalence rate based on parent assessments
(11%) in this study does fall within the range for the other studies. The
study of August et al ( 37) used an
initial screen for disruptive behaviors that employed a rather conservative
threshold, so as to minimize false positive identifications, followed by more
detailed screening to diagnose the particular disorders. This use of a conservative
initial screening method may have led to an underestimation of prevalence. | Table 3Studies assessing prevalence of ADHD symptoms as defined by DSM-III-R in
US children and adolescents |
A seventh study ( 39) involved a
slightly older population than the other studies (aged 9-17 years, mean age
13 years) and reported a somewhat lower prevalence rate of 4.5% (based on
parent reports). This is in keeping with other data (e.g. 22) which indicate a decrease in prevalence with increasing
age into adolescence and adulthood. Simonoff et al ( 40) also reported a low prevalence rate (2.4%) for an older
population (aged 8-16 years); this was a population of Caucasian twin pairs
and thus may not be representative of the general population. Finally, Lewinsohn
et al ( 41) studied an adolescent population
and reported a particularly low prevalence rate of 0.41%. However, this value
was based on subject self reports of symptoms, and adolescents are known to
be poor reporters of their own symptoms ( 42). Twelve studies of non-US populations were identified which employed DSM-III-R
diagnostic criteria. For one of these studies ( 43)
the same data were reported in terms of DSM-IV criteria in a separate paper
( 44). The earlier paper was therefore
excluded from this analysis and the later paper was reviewed with the other
papers using DSM-IV criteria. The remaining 11 studies are summarized in Table . Four of these studies ( 23, 45- 47) involved adolescents (for Gomez-Beneyto et al [ 23] a 15-year age group) and report low prevalence
rates (1.8-3.9%) as would be expected for this older population. The remaining
eight studies (including the two younger age groups included in study of Gomez-Beneyto
et al [ 23]) involved children aged
5-15 years and with a mean age of 6.5-11 years, comparable to that of the
six US studies analyzed. Prevalence rates for these eight studies ranged between
3.9% and 14.4%. | Table 4Studies assessing prevalence of ADHD symptoms as defined by DSM-III-R in
non-US children and adolescents |
DSM-IV studies A total of 19 studies have now been published which used the DSM-IV diagnostic
criteria; this included eight studies of US populations and 11 from non-US
populations. Two of these studies also present prevalence data according to
DSM-III-R criteria ( 16, 17) and DSM-III criteria ( 16). Of the eight US studies, one was in adults ( 48)
and one used more lenient criteria in order to select sufficient girls for
further study ( 49) and hence will not
be discussed further. Six studies reported the prevalence of ADHD symptoms
(i.e. fulfilment of criteria A only) and gave rates of 9.5-16.1% (Table ). When only the four studies of children
with mean ages of approximately 8-10 years are considered, this gives a prevalence
range of 11.4-16.1%. Most of these studies diagnosed ADHD on the basis of
either teacher or parent reports; only Rowland et al ( 50) employed teacher and parent reports of symptoms. Importantly,
the data reported by Rowland et al are within the range reported for studies
using a single informant and thus suggest that data from single-informant
studies may be valid for comparing prevalence rates. Wolraich et al ( 18) reported the prevalence of ADHD both
according to symptoms alone (16.1%) and when functional impairment was also
required (6.8%). This indicates that estimates of ADHD prevalence based on
symptom assessment alone are likely to be overestimates. However, such data
may be useful to assess the relative prevalence of ADHD symptoms in different
countries and cultures with the caveat that this should not be equated with
the actual prevalence of ADHD. | Table 5Studies assessing prevalence of ADHD symptoms as defined by DSM-IV in US
children and adolescents |
Of the 11 studies of non-US populations, all except one ( 51) used teacher and/or parent assessments of ADHD symptoms.
Of these 10 studies, nine were in children with a mean age between 7 and 11
years. These nine studies reported rates of ADHD symptoms ranging from 2.4
to 19.8% (Table ). Of these studies,
five reported rates in the narrower range of 16.0-19.8%, which is at the high
end of the range reported for the six US studies which spanned a similar age
range. The studies that reported lower rates (2.4-7.5%) were the two studies
of Australian populations, the only study of an Icelandic population, and
the Swedish study. The low rates in the Australian, Icelandic and Swedish
studies may reflect cultural differences in these populations. However, it
is interesting to note that in one of the Australian studies ( 52), which reported the lowest prevalence rate (2.4%) when
using combined teacher and parent assessments, the prevalence rates based
on parent assessments alone (9.9%) and teacher assessments alone (8.8%) were
similar to those reported in the US studies. Two studies additionally reported
prevalence rates based on functional impairment and these rates were lower
than those for symptoms alone - symptom prevalence, 7.5%; impairment prevalence,
6.8% ( 19); symptom prevalence, 15.8%;
impairment prevalence, 0.2% ( 53) -
in agreement with the findings of Wolraich et al ( 18). | Table 6Studies assessing prevalence of ADHD symptoms as defined by DSM-IV in non-US
children and adolescents |
Comparison of prevalence rates Table shows the range of prevalence
rates for US and non-US populations for the three DSM diagnostic criteria
when outlying values have been excluded. Comparison of the prevalence range
for the US studies shows that the highest prevalence is reported when using
DSM-IV criteria, as has previously been shown by Wolraich et al ( 17) and Baumgaertel et al ( 16).
The non-US studies also showed a higher prevalence of ADHD when using DSMIV
diagnoses. As Table shows, the range
of prevalence reported in the non-US studies is, for each diagnostic system,
similar to that reported in the US studies. | Table 7Prevalence ranges for ADHD/ADD-H according to DSM diagnostic criteria for
US and non-US populations |
Several of the non-US DSM-III-R and DSM-IV studies found fairly low prevalence
figures, between 2.4 and 7.5%. The countries included in the low-prevalence
group are Sweden (2/2 studies in this population), Italy (1/1 study in this
population), Australia (2/2 studies in this population), Iceland (1/1 study
in this population), and Spain (1/1 study, but only for 11 years age group).
This may reflect a true lower prevalence in these countries but further studies
are required to confirm this. These countries are not represented in the studies
using DSM-III diagnostic criteria. The results of studies using DSM criteria suggest that the prevalence of
ADHD/ADD-H is at least as high in many non-US children as in US children.
Certain populations may have a lower prevalence of ADHD symptoms (e.g., Iceland,
Australia, Italy, and Sweden), but this cannot be concluded on the basis of
the available data. Direct comparisons between different populations are required
to truly assess the relative prevalence of ADHD symptoms in different cultures
and countries. To date, only one such study has been performed. Gadow et al
( 15) reported on the prevalence of
ADHD symptoms in a sample of 600 Ukrainian children (aged 10-12) and an age-matched
sam ple of 443 US children. The Ukrainian children were a sample of those
living within 30 km of the Chernobyl nuclear power plant who were evacuated
to Kyiv and remained living there 10 years later. This study reported a prevalence
of ADHD symptoms of 19.8% for Ukrainian children compared with 9.7% for the
US sample. It is unclear why the prevalence of ADHD symptoms should be so
much higher in the sample of Ukrainian children. It is possible that the higher
Ukrainian prevalence reflects the environmental adversity and psychosocial
dislocation associated with the Chernobyl disaster, but we can draw no firm
conclusions in the absence of an appropriate Ukrainian control group. While the populations studied in the papers included in this report are
not necessarily representative of all child populations worldwide, they are
sufficient to demonstrate that ADHD is not purely an American disorder and
that the prevalence of this behavioral disorder in many countries is in the
same range as that in the USA. Although a number of prevalence studies were
not included in this analysis because they employed other diagnostic criteria,
such as the ICD-9 and ICD-10 criteria, the populations they studied are for
the most part represented in the selection of studies included in this analysis.
Thus, the decision to include only studies employing DSM diagnostic criteria
was unlikely to make the selected studies unrepresentative of the populations
studied to date. Recognition of ADHD as a disorder affecting a significant percentage of
children in many countries has important implications for the psychiatric
care of children. Numerous studies have shown that appropriate management
can significantly impact on the symptoms of ADHD and thus help children and
their families overcome and live with the burden of this disorder ( 54, 55). Management
options include: educational strategies which help the child and adolescent
achieve their academic potential at school and college; behavioral treatments
aimed at teaching the child, their parents and teachers how to modify problem
behaviors; and pharmacotherapy which has been shown to be highly effective
for the long-term control of core symptoms. However, in the absence of adequate
recognition of the disorder by the medical community, the teaching profession
and the public in general, children with this behavioral disorder are unlikely
to receive the assistance they require to achieve their full potential, at
school, at home, and into adulthood. In conclusion, the data from studies using DSM criteria to assess the prevalence
of ADHD in representative child and adolescent populations suggest that there
is no convincing difference between the prevalence of this disorder in the
USA and most other countries or cultures. It is difficult to make exact comparisons
between countries because the estimated prevalence is highly influenced by
the means of assessment and the type of sample recruited. However, the range
of prevalence rates for DSM symptoms reported in US child populations appears
to fall within those reported for non-US child populations (except for those
of Iceland, Australia, Italy and Sweden). One limitation of the literature we reviewed is the reliance of many studies
on rating scale measures rather than interviews with patients and parents.
Unlike rating scale methods, interview-based procedures come close to reproducing
the results one might expect from a clinical evaluation and are better able
to incorporate the impairment and pervasiveness criteria of the DSM diagnoses
of ADHD. Further interview-based studies assessing the prevalence of ADHD
as defined by the DSM-IV criteria, and directly comparing the prevalence in
different countries, are required to provide a clearer picture of the burden
of ADHD worldwide. We have also relied on the DSM as a method of comparing
the cross-cultural prevalence of ADHD. As discussed by Hartman et al ( 56), it is possible that improved operationalization
of symptoms could lead to increased measurement precision and a better assessment
of the cross-national validity of diagnostic categories. In addition, this
research needs to be followed up into clinical practice, with a better awareness
of this disorder and the effective means of alleviating the associated symptoms
and its burden on the individual and society as a whole. This work was supported in part by the National Institute of Health grants
R01MH57934, R01HD37694, R13MH59126 (S. Faraone, PI) and by a grant from Johnson
and Johnson (J. Biederman, PI). 1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994. 2. Biederman J. Wilens T. Mick E, et al. Is ADHD a risk factor for psychoactive substance use disorders?
Findings from a four-year prospective follow-up study . J Am Acad Child Adolesc Psychiatry. 1997;36:21–29. [PubMed] 3. Mash EJ. Johnston C. Parental perceptions of child behavior problems, parenting
self-esteem, and mothers' reported stress in younger and older hyperactive
and normal children. J Consult Clin Psychol. 1983;51:86–99. [PubMed] 4. Murphy KR. Barkley RA. Parents of children with attentiondeficit/ hyperactivity disorder:
psychological and attentional impairment. Am J Orthopsychiatry. 1996;66:93–102. [PubMed] 5. Taylor E. Sandberg S. Hyperactive behavior in English schoolchildren: a questionnaire
survey. J Abnorm Child Psychol. 1984;12:143–155. [PubMed] 6. Taylor A. The overactive child. London: The Spastics Society; 1986. 7. Gleeson D. Parker D. Hyperactivity in a group of children referred to a Scottish
Child Guidance Service: a significant problem. Br J Educ Psychol. 1989;59:262–265. [PubMed] 8. Miller RG., Jr Palkes HS., Jr Stewart MA., Jr Hyperactive children in suburban elementary schools. Child Psychiatry Hum Dev. 1973;4:121–127. [PubMed] 9. Lambert NM. Sandoval J. Sassone D. Prevalence of hyperactivity in elementary school children as
a function of social system definers. Am J Orthopsychiatry. 1978;48:446–463. [PubMed] 10. Safer D. Allen RP. Hyperactive children: diagnosis and management. Baltimore: University Park Press; 1976. 11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington: American Psychiatric Association; 1980. 12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., rev. Washington: American Psychiatric Association; 1987. 13. Magnusson P. Smari J. Gretarsdottir H, et al. Attentiondeficit/ hyperactivity symptoms in Icelandic schoolchildren:
assessment with the Attention Deficit/Hyperactivity Rating Scale-IV. Scand J Psychol. 1999;40:301–306. [PubMed] 14. Pineda D. Ardila A. Rosselli M, et al. Prevalence of attentiondeficit/ hyperactivity disorder symptoms
in 4- to 17-year-old children in the general population. J Abnorm Child Psychol. 1999;27:455–462. [PubMed] 15. Gadow KD. Nolan EE. Litcher L, et al. Comparison of attentiondeficit/ hyperactivity disorder symptom
subtypes in Ukrainian schoolchildren. J Am Acad Child Adolesc Psychiatry. 2000;39:1520–1527. [PubMed] 16. Baumgaertel A. Wolraich ML. Dietrich M. Comparison of diagnostic criteria for attention deficit disorders
in a German elementary school sample. J Am Acad Child Adolesc Psychiatry. 1995;34:629–638. [PubMed] 17. Wolraich ML. Hannah JN. Pinnock TY, et al. Comparison of diagnostic criteria for attention-deficit hyperactivity
disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry. 1996;35:319–324. [PubMed] 18. Wolraich ML. Hannah JN. Baumgaertel A, et al. Examination of DSM-IV criteria for attention deficit/hyperactivity
disorder in a county-wide sample. J Dev Behav Pediatr. 1998;19:162–168. [PubMed] 19. Graetz BW. Sawyer MG. Hazell PL, et al. Validity of DSM-IV ADHD subtypes in a nationally representative
sample of Australian children and adolescents. J Am Acad Child Adolesc Psychiatry. 2001;40:1410–1417. [PubMed] 20. Swanson JM. Sergeant JA. Taylor E, et al. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet. 1998;351:429–433. [PubMed] 21. Brown RT. Freeman WS. Perrin JM, et al. Prevalence and assessment of attention-deficit/hyperactivity
disorder in primary care settings. Pediatrics. 2001;107 22. Cohen P. Cohen J. Kasen S, et al. An epidemiological study of disorders in late childhood and
adolescence óI. Age- and genderspecific prevalence. J Child Psychol Psychiatry. 1993;34:851–867. [PubMed] 23. Gomez-Beneyto M. Bonet A. Catala MA, et al. Prevalence of mental disorders among children in Valencia,
Spain. Acta Psychiatr Scand. 1994;89:352–357. [PubMed] 24. Breton JJ. Bergeron L. Valla JP, et al. Quebec child mental health survey: prevalence of DSM-III-R
mental health disorders. J Child Psychol Psychiatry. 1999;40:375–384. [PubMed] 25. Yao KN. Solanto MV. Wender EH. Prevalence of hyperactivity among newly immigrated Chinese-American
children. J Dev Behav Pediatr. 1988;9:367–373. [PubMed] 26. Newcorn JH. Halperin JM. Schwartz S, et al. Parent and teacher ratings of attention-deficit hyperactivity
disorder symptoms: implications for case identification. J Dev Behav Pediatr. 1994;15:86–91. [PubMed] 27. King C. Young RD. Attentional deficits with and without hyperactivity: teacher
and peer perceptions. J Abnorm Child Psychol. 1982;10:483–495. [PubMed] 28. Shekim WO. Kashani J. Beck N, et al. The prevalence of attention deficit disorders in a rural midwestern
community sample of nine-year-old children. J Am Acad Child Psychiatry. 1985;24:765–770. [PubMed] 29. Barkley RA. Fischer M. Edelbrock C, et al. The adolescent outcome of hyperactive children diagnosed by
research criteria óIII. Mother-child interactions, family conflicts and maternal
psychopathology. J Child Psychol Psychiatry. 1991;32:233–255. [PubMed] 30. Fischer M. Barkley RA. Fletcher KE, et al. The stability of dimensions of behavior in ADHD and normal
children over an 8-year followup. J Abnorm Child Psychol. 1993;21:315–337. [PubMed] 31. McGee R. Feehan M. Williams S, et al. DSM-III disorders in a large sample of adolescents. J Am Acad Child Adolesc Psychiatry. 1990;29:611–619. [PubMed] 32. Schaughency E. McGee R. Raja SN, et al. Self-reported inattention, impulsivity, and hyperactivity at
ages 15 and 18 years in the general population. J Am Acad Child Adolesc Psychiatry. 1994;33:173–184. [PubMed] 33. 34. Leung PW. Luk SL. Ho TP, et al. The diagnosis and prevalence of hyperactivity in Chinese schoolboys. Br J Psychiatry. 1996;168:486–496. [PubMed] 35. Cuffe SP. McKeown RE. Jackson KL, et al. Prevalence of attention- deficit/hyperactivity disorder in
a community sample of older adolescents. J Am Acad Child Adolesc Psychiatry. 2001;40:1037–1044. [PubMed] 36. August GJ. Garfinkel BD. Behavioral and cognitive subtypes of ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28:739–748. [PubMed] 37. August GJ., III Realmuto GM., III MacDonald AW, III, et al. Prevalence of ADHD and comorbid disorders among elementary
school children screened for disruptive behavior. J Abnorm Child Psychol. 1996;24:571–595. [PubMed] 38. Pelham WE., Jr Gnagy EM., Jr Greenslade KE, Jr, et al. Teacher ratings of DSM-III-R symptoms for the disruptive behavior
disorders. J Am Acad Child Adolesc Psychiatry. 1992;31:210–218. [PubMed] 39. Shaffer D. Fisher P. Dulcan MK, et al. The NIMH Diagnostic Interview Schedule for Children Version
2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance
in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental
Disorders Study. J Am Acad Child Adolesc Psychiatry. 1996;35:865–877. [PubMed] 40. Simonoff E. Pickles A. Meyer JM, et al. The Virginia Twin Study of Adolescent Behavioral Development.
Influences of age, sex, and impairment on rates of disorder. Arch Gen Psychiatry. 1997;54:801–808. [PubMed] 41. Lewinsohn PM. Hops H. Roberts RE, et al. Adolescent psychopathology: I. Prevalence and incidence of
depression and other DSM-III-R disorders in high school students. J Abnorm Psychol. 1993;102:133–144. [PubMed] 42. Barkley RA. Anastopoulos AD. Guevremont DC, et al. Adolescents with ADHD: patterns of behavioral adjustment, academic
functioning, and treatment utilization. J Am Acad Child Adolesc Psychiatry. 1991;30:752–761. [PubMed] 43. Kadesjo B. Gillberg C. Attention deficits and clumsiness in Swedish 7-year-old children. Dev Med Child Neurol. 1998;40:796–804. [PubMed] 44. Kadesjo B. Gillberg C. The comorbidity of ADHD in the general population of Swedish
school-age children. J Child Psychol Psychiatry. 2001;42:487–492. [PubMed] 45. Zohar AH. Ratzoni G. Pauls DL, et al. An epidemiological study of obsessive-compulsive disorder and
related disorders in Israeli adolescents. J Am Acad Child Adolesc Psychiatry. 1992;31:1057–1061. [PubMed] 46. Verhulst FC. van der Ende J. Ferdinand RF, et al. The prevalence of DSM-III-R diagnoses in a national sample
of Dutch adolescents. Arch Gen Psychiatry. 1997;54:329–336. [PubMed] 47. Fergusson DM. Horwood LJ. Lynskey MT. Prevalence and comorbidity of DSM-III-R diagnoses in a birth
cohort of 15 year olds. J Am Acad Child Adolesc Psychiatry. 1993;32:1127–1134. [PubMed] 48. Murphy K. Barkley AR. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers:
implications for clinical diagnosis. J Attention Disord. 1996;1:147–161. 49. Carlson CL. Tamm L. Gaub M. Gender differences in children with ADHD, ODD, and co-occurring
ADHD/ODD identified in a school population. J Am Acad Child Adolesc Psychiatry. 1997;36:1706–1714. [PubMed] 50. Rowland AS. Umbach DM. Catoe KE, et al. Studying the epidemiology of attention-deficit hyperactivity
disorder: screening method and pilot results. Can J Psychiatry. 2001;46:931–940. [PubMed] 51. Rohde LA. Barbosa G. Polanczyk G, et al. Factor and latent class analysis of DSM-IV ADHD symptoms in
a school sample of Brazilian adolescents. J Am Acad Child Adolesc Psychiatry. 2001;40:711–718. [PubMed] 52. Gomez R. Harvey J. Quick C, et al. DSM-IV AD/HD: confirmatory factor models, prevalence, and gender
and age differences based on parent and teacher ratings of Australian primary
school children. J Child Psychol Psychiatry. 1999;40:265–274. [PubMed] 53. Essau CA. Groen G. Conradt J, et al. Frequency, comorbidity and psychosocial correlates of attention-deficit/hyperactivity
disorder. Results of a Bremen adolescent study. Fortschr Neurol Psychiatr. 1999;67:296–305. [PubMed] 54. Multimodal Treatment Study Group. A 14-month randomized clinical trial of treatment strategies
for attention-deficit/hyperactivity disorder: the multimodal treatment study
of children with ADHD. Arch Gen Psychiatry. 1999. pp. 1073–1086. [PubMed] 55. American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child
with attention-deficit/hyperactivity disorder. Pediatrics. 2001. pp. 1033–1044. [PubMed] 56. Hartman CA. Hox J. Mellenbergh GL, et al. DSM-IV internal construct validity: when a taxonomy meets data. J Child Psychol Psychiatry. 2001;42:817–836. [PubMed] 57. Bauermeister JJ. Alegria M. Bird HR, et al. Are attentional-hyperactivity deficits unidimensional or multidimensional
syndromes? Empirical findings from a community survey. J Am Acad Child Adolesc Psychiatry. 1992;31:423–431. [PubMed] 58. Szatmari P. Offord DR. Boyle MH. Ontario Child Health Study: prevalence of attention deficit
disorder with hyperactivity. J Child Psychol Psychiatry. 1989;30:219–230. [PubMed] 59. Shen YC. Wang YF. Yang XL. An epidemiological investigation of minimal brain dysfunction
in six elementary schools in Beijing. J Child Psychol Psychiatry. 1985;26:777–787. [PubMed] 60. Bhatia MS. Nigam VR. Bohra N, et al. Attention deficit disorder with hyperactivity among paediatric
outpatients. J Child Psychol Psychiatry. 1991;32:297–306. [PubMed] 61. Verhulst FC. Berden GF. Sanders-Woudstra JA. Mental health in Dutch children (II). The prevalence of psychiatric
disorder and relationship between measures. Acta Psychiatr Scand. 1985;72(Suppl. 324):1–45. [PubMed] 62. Puura K. Almqvist F. Tamminen T, et al. Psychiatric disturbances among prepubertal children in southern
Finland. Soc Psychiatry Psychiatr Epidemiol. 1998;33:310–318. [PubMed] 63. Gallucci F. Bird HR. Berardi C, et al. Symptoms of attention-deficit hyperactivity disorder in an
Italian school sample: findings of a pilot study. J Am Acad Child Adolesc Psychiatry. 1993;32:1051–1058. [PubMed] 64. Kanbayashi Y. Nakata Y. Fujii K, et al. ADHD-related behavior among non-referred children: parents'
ratings of DSM-III-R symptoms. Child Psychiatry Hum Dev. 1994;25:13–29. [PubMed] 65. Landgren M. Pettersson R. Kjellman B, et al. ADHD, DAMP and other neurodevelopmental/psychiatric disorders
in 6-year-old children: epidemiology and co-morbidity. Dev Med Child Neurol. 1996;38:891–906. [PubMed] 66. Wang YC. Chong MY. Chou WJ, et al. Prevalence of attention deficit hyperactivity disorder in primary
school children in Taiwan. J Formos Med Assoc. 1993;92:133–138. [PubMed] 67. Gimpel GA. Kuhn BR. Maternal report of attention deficit hyperactivity disorder
symptoms in preschool children. Child Care Health Dev. 2000;26:163–176. [PubMed] 68. Hudziak JJ. Heath AC. Madden PF, et al. Latent class and factor analysis of DSM-IV ADHD: a twin study
of female adolescents. J Am Acad Child Adolesc Psychiatry. 1998;37:848–857. [PubMed] 69. Nolan EE. Gadow KD. Sprafkin J. Teacher reports of DSM-IV ADHD, ODD, and CD symptoms in schoolchildren. J Am Acad Child Adolesc Psychiatry. 2001;40:241–249. [PubMed] 70. Guardiola A. Fuchs FD. Rotta NT. Prevalence of attention-deficit hyperactivity disorders in
students. Comparison between DSM-IV and neuropsychological criteria. Arq Neuropsiquiatr. 2000;58:401–407. [PubMed] 71. Rohde LA. Biederman J. Busnello EA, et al. ADHD in a school sample of Brazilian adolescents: a study of
prevalence, comorbid conditions, and impairments. J Am Acad Child Adolesc Psychiatry. 1999;38:716–722. [PubMed] 72. Pineda DA. Lopera F. Henao GC, et al. Confirmation of the high prevalence of attention deficit disorder
in a Colombian community. Rev Neurol. 2001;32:217–222. [PubMed]
|
This article has been